Activating mutations of the Wnt/β-catenin pathway occur frequently in HCC, and immunosuppression in the tumor microenvironment based on activation of this signal in liver cancer is presumed to occur via downregulation of CCL5 [55]. This evidence concerns the gene CCL5 and hepatocellular carcinoma.